USANA Health Sciences Updates FY24 Net Sales Outlook From $850M - $920M To $850M - $880M (Est $883.518M) And EPS Outlook From $2.40 - $3.00 To $2.40 - $2.55 (Est $2.78)
Portfolio Pulse from Benzinga Newsdesk
USANA Health Sciences has updated its FY24 net sales outlook from $850M - $920M to $850M - $880M, and its EPS outlook from $2.40 - $3.00 to $2.40 - $2.55. The revised estimates are below market expectations.
July 23, 2024 | 8:56 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
USANA Health Sciences has revised its FY24 net sales and EPS outlook downward. The new net sales range is $850M - $880M, and the new EPS range is $2.40 - $2.55, both below market expectations.
The downward revision of both net sales and EPS outlooks indicates potential challenges in USANA's business performance. The new estimates are below market expectations, which is likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100